A Case Series of Patients with Isolated IgG4-related Hypophysitis Treated with Rituximab

Abstract

Rituximab treatment for IgG4-related hypophysitis resulted in sustained remission in 2 patients treated early in the disease process but only achieved partial response in a patient with chronic disease, suggesting that early therapeutic intervention may be crucial in order to avoid irreversible changes.